ANALYSIS
Cost-effectiveness analysis, including economic modelling for: medicines, medical devices, procedures, interventions, diagnostics and treatments with the aim of offering support for HTA dossiers.
To bring about an improvement in the health status of the population multidisciplinary public health approaches are required. Evidence is needed about the efficacy, feasibility, cost-effectiveness and budget impact of the potential public health interventions. When these interventions are implemented, their process, outcome and impact also need to be monitored and evaluated. Syreon Research Institute provides high-quality research to collect, and interpret the evidence needed for public health decision-making both for policy-makers and the pharmaceutical industry.
SYREON RESEARCH INSTITUTE OFFERS
- adaptation of HTA studies to local data and costs
- budget impact analysis (BIA)
- pricing strategy for the pharmaceutical industry
- cost analysis, economic modelling, bio statistical analysis
- health policy and public health studies, epidemiological studies
- evaluation and preparation of scientific publications, conferences